The Advisory Team at Blue Lake Biotechnology provides strategic guidance and expert insights to support the development of PIV5-based vaccines. Comprised of experienced advisors, this team leverages their extensive knowledge in biotechnology, regulatory affairs, and clinical trials to assist in navigating the complexities of vaccine development and securing FDA approval for the company's phase I trial.
View all